دورية أكاديمية
Efficacy and one-year outcomes of Luminor® paclitaxel-coated drug-eluting balloon in the treatment of popliteal artery atherosclerosis lesions
| العنوان: | Efficacy and one-year outcomes of Luminor® paclitaxel-coated drug-eluting balloon in the treatment of popliteal artery atherosclerosis lesions |
|---|---|
| المؤلفون: | Pecoraro F., Dinoto E., Pakeliani D., Mirabella D., Ferlito F., Bajardi G. |
| المساهمون: | Pecoraro F., Dinoto E., Pakeliani D., Mirabella D., Ferlito F., Bajardi G. |
| بيانات النشر: | Elsevier Inc. |
| سنة النشر: | 2021 |
| المجموعة: | IRIS Università degli Studi di Palermo |
| مصطلحات موضوعية: | Angioplasty, Critical limb ischemia, Drug eluting balloon, Endovascular, Popliteal artery, Settore MED/22 - Chirurgia Vascolare |
| الوصف: | Purpose: Reporting outcomes with a new generation paclitaxel eluting balloon (Luminor®; iVascular, Vascular, S.L.U., Barcelona, Spain) in the popliteal district. Endovascular treatment of popliteal artery atherosclerotic disease is still debated without definitive evidences. Methods: From January to June 2019, patients’ data presenting popliteal artery atherosclerotic diseases and treated with the Luminor® (iVascular) drug eluting balloon (DEB) were prospectively collected. Critical limb ischemia (CLI) or severe claudication associated with popliteal artery stenosis >50% were the inclusion criteria. Measured outcomes were technical success, early and late results; including mortality, morbidity, symptoms recurrence, amputation, ankle-brachial index (ABI), survival, primary patency, secondary patency, freedom from restenosis. Median follow-up was 22.43 ± 4 (mean:21.58; IQR:20-24) months. Results: Of the 33 included patients, 28 (85%) were diagnosed with CLI, with a mean preoperative run-off score of 5.39 (r:0-10; SD:3) and a chronic popliteal occlusion in 21 (64%). Technical success was achieved in all cases. Perioperative mortality was observed in 1 (3%) patient and perioperative complications in 2 (6%). During the follow-up were reported 2 symptoms recurrence; a significant ABI increase (0.57; IQR:0.41-0.47 vs. 0.69; IQR:0.50-0.67; P < 0.01); 1 (3%) major and 2 (6%) minor amputations. Estimated 24 months survival, primary patency, secondary patency, and freedom from restenosis were 97%, 96.9%, 100%, and 93.8% respectively. Conclusions: In this prospective study, the use of the Luminor® (iVascular) was safe and effective in addressing atherosclerotic popliteal artery lesions. Larger studies with longer term-outcomes are required to assess the durability of this device in the popliteal artery. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/33951533; info:eu-repo/semantics/altIdentifier/wos/WOS:000726775700046; numberofpages:8; journal:ANNALS OF VASCULAR SURGERY; http://hdl.handle.net/10447/514438Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85106589642 |
| DOI: | 10.1016/j.avsg.2021.04.015 |
| الإتاحة: | https://doi.org/10.1016/j.avsg.2021.04.015Test http://hdl.handle.net/10447/514438Test |
| حقوق: | info:eu-repo/semantics/closedAccess |
| رقم الانضمام: | edsbas.1C6896B3 |
| قاعدة البيانات: | BASE |
| ResultId |
1 |
|---|---|
| Header |
edsbas BASE edsbas.1C6896B3 857 3 Academic Journal academicJournal 856.820373535156 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.1C6896B3&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doi.org/10.1016/j.avsg.2021.04.015# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Efficacy and one-year outcomes of Luminor® paclitaxel-coated drug-eluting balloon in the treatment of popliteal artery atherosclerosis lesions
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Pecoraro+F%2E%22">Pecoraro F.</searchLink><br /><searchLink fieldCode="AR" term="%22Dinoto+E%2E%22">Dinoto E.</searchLink><br /><searchLink fieldCode="AR" term="%22Pakeliani+D%2E%22">Pakeliani D.</searchLink><br /><searchLink fieldCode="AR" term="%22Mirabella+D%2E%22">Mirabella D.</searchLink><br /><searchLink fieldCode="AR" term="%22Ferlito+F%2E%22">Ferlito F.</searchLink><br /><searchLink fieldCode="AR" term="%22Bajardi+G%2E%22">Bajardi G.</searchLink> ) Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Pecoraro F.<br />Dinoto E.<br />Pakeliani D.<br />Mirabella D.<br />Ferlito F.<br />Bajardi G. ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Elsevier Inc. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2021 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => IRIS Università degli Studi di Palermo ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Angioplasty%22">Angioplasty</searchLink><br /><searchLink fieldCode="DE" term="%22Critical+limb+ischemia%22">Critical limb ischemia</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+eluting+balloon%22">Drug eluting balloon</searchLink><br /><searchLink fieldCode="DE" term="%22Endovascular%22">Endovascular</searchLink><br /><searchLink fieldCode="DE" term="%22Popliteal+artery%22">Popliteal artery</searchLink><br /><searchLink fieldCode="DE" term="%22Settore+MED%2F22+-+Chirurgia+Vascolare%22">Settore MED/22 - Chirurgia Vascolare</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Purpose: Reporting outcomes with a new generation paclitaxel eluting balloon (Luminor®; iVascular, Vascular, S.L.U., Barcelona, Spain) in the popliteal district. Endovascular treatment of popliteal artery atherosclerotic disease is still debated without definitive evidences. Methods: From January to June 2019, patients’ data presenting popliteal artery atherosclerotic diseases and treated with the Luminor® (iVascular) drug eluting balloon (DEB) were prospectively collected. Critical limb ischemia (CLI) or severe claudication associated with popliteal artery stenosis >50% were the inclusion criteria. Measured outcomes were technical success, early and late results; including mortality, morbidity, symptoms recurrence, amputation, ankle-brachial index (ABI), survival, primary patency, secondary patency, freedom from restenosis. Median follow-up was 22.43 ± 4 (mean:21.58; IQR:20-24) months. Results: Of the 33 included patients, 28 (85%) were diagnosed with CLI, with a mean preoperative run-off score of 5.39 (r:0-10; SD:3) and a chronic popliteal occlusion in 21 (64%). Technical success was achieved in all cases. Perioperative mortality was observed in 1 (3%) patient and perioperative complications in 2 (6%). During the follow-up were reported 2 symptoms recurrence; a significant ABI increase (0.57; IQR:0.41-0.47 vs. 0.69; IQR:0.50-0.67; P < 0.01); 1 (3%) major and 2 (6%) minor amputations. Estimated 24 months survival, primary patency, secondary patency, and freedom from restenosis were 97%, 96.9%, 100%, and 93.8% respectively. Conclusions: In this prospective study, the use of the Luminor® (iVascular) was safe and effective in addressing atherosclerotic popliteal artery lesions. Larger studies with longer term-outcomes are required to assess the durability of this device in the popliteal artery. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => info:eu-repo/semantics/altIdentifier/pmid/33951533; info:eu-repo/semantics/altIdentifier/wos/WOS:000726775700046; numberofpages:8; journal:ANNALS OF VASCULAR SURGERY; http://hdl.handle.net/10447/514438; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85106589642 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1016/j.avsg.2021.04.015 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1016/j.avsg.2021.04.015<br />http://hdl.handle.net/10447/514438 ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => info:eu-repo/semantics/closedAccess ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.1C6896B3 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1016/j.avsg.2021.04.015
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Angioplasty
[Type] => general
)
[1] => Array
(
[SubjectFull] => Critical limb ischemia
[Type] => general
)
[2] => Array
(
[SubjectFull] => Drug eluting balloon
[Type] => general
)
[3] => Array
(
[SubjectFull] => Endovascular
[Type] => general
)
[4] => Array
(
[SubjectFull] => Popliteal artery
[Type] => general
)
[5] => Array
(
[SubjectFull] => Settore MED/22 - Chirurgia Vascolare
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Efficacy and one-year outcomes of Luminor® paclitaxel-coated drug-eluting balloon in the treatment of popliteal artery atherosclerosis lesions
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Pecoraro F.
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Dinoto E.
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Pakeliani D.
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Mirabella D.
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ferlito F.
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Bajardi G.
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Pecoraro F.
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Dinoto E.
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Pakeliani D.
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Mirabella D.
)
)
)
[10] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ferlito F.
)
)
)
[11] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Bajardi G.
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2021
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
)
)
)
)
)
)
|
| IllustrationInfo |